Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page
- Check4 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a backend version update with no user-facing changes.SummaryDifference0.1%

- Check69 days agoChange DetectedMinor version update noted: v3.4.2 has been added and v3.4.1 removed. This appears to be a maintenance change rather than a change to study data or user actions.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no visible changes to study details or page layout are observed.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.